Brainwave Changes and Cranial Electrotherapy Stimulation
Primary Purpose
Psychiatric Disorder
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cranial Electric Stimulation
Sponsored by
About this trial
This is an interventional diagnostic trial for Psychiatric Disorder
Eligibility Criteria
Inclusion Criteria:
- Inclusion Criteria All prospective subjects will be active duty service members who are enrolled in PCS
Exclusion Criteria:
• Subjects will be excluded who have a seizure disorder, a cardiac pacemaker, or active untreated vertigo.
- Subjects will be excluded if they have used CES the day of the study. However, they may participate in the study the following day.
- Female subjects who are or who suspect they may be pregnant.
- Subjects will also be excluded who are clinically judged by the investigators to be actively suicidal or have another psychiatric condition that would require inpatient hospitalization
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Brainwave
Arm Description
Brainwave analysis after cranial electric stimulation
Outcomes
Primary Outcome Measures
Quantitative EEG Analysis
The investigators used a commercially available EEG headset (Neurosky MindSet) in combination with EEG software (SmartMind) to obtain and analyze the Quantitative EEG from the subjects. The combination of the EEG headset with the software identified the five brainwave frequencies that are clinically relevant in studying EEG activity: Alpha, Beta, Delta, Gamma, and Theta. The combination of the headset and software reported changes in brainwave amplitude in microvolts for each brainwave frequency. Alpha waves increase with relaxation and drowsiness; and Beta waves, increase with wakefulness and concentration. Delta and Theta waves increase during meditative states and Gamma may suggest brain synchronicity.
Secondary Outcome Measures
Full Information
NCT ID
NCT03298308
First Posted
September 20, 2017
Last Updated
September 26, 2017
Sponsor
Walter Reed National Military Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03298308
Brief Title
Brainwave Changes and Cranial Electrotherapy Stimulation
Official Title
Effects of Cranial Electric Stimulation on Brain Wave Activity: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
May 27, 2016 (Actual)
Primary Completion Date
May 10, 2017 (Actual)
Study Completion Date
May 10, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Walter Reed National Military Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study explored relationships between cranial electric stimulation and brainwave changes.
Detailed Description
This pilot study will collect data from properly consented and subsequently enrolled subjects in the Psychiatric Continuity Service (PCS). All PCS programs provide both group and individual therapy designed to address various chronic mental health disorders such as major depressive disorder, anxiety, and post-traumatic stress disorder (PTSD). Group therapy and education focus on how chronic mental health disorders develop, the recovery process and psychosocial stressors that may contribute to both improvement in functioning and declines. Every patient is different with regard to how his or her program is tailored, but everyone receives weekly individual counseling from behavioral health providers (psychiatrists, psychologists and clinical social workers). PCS works in tandem with other treatment providers, case managers and chains of command. PCS is also equipped to transfer patients in need to higher levels of care in cases of emergency.
All prospective subjects will be active duty service members who are enrolled in PCS. Subjects will be recruited by the Associate Investigator (AI) or Principal Investigator (PI). The primary outcome measure is the exploration of changes in specific brain wave activity in response to a Cranial Electrotherapy Stimulation (CES) intervention.
Subjects who agree to participate in the study will complete a consent and Health Insurance Portability and Accountability Act (HIPAA) form and baseline questionnaires. In addition, since the fetal effects of the CES device is not known;, female subjects will have to present a negative pregnancy test within one week of the research intervention. Those female subjects to which pregnancy is unlikely (i.e. hysterectomy), will be excluded from a pregnancy test if this information can be verified medically. will self-report regarding as it applies menstrual cycle length and birth control method used within the last two weeks.
The intervention will take place during clinic hours. This will be a one-time intervention that will last approximately 1 to 1 ½ hours. The AI will prepare the CES device, briefly explain the function, and place the CES ear clips on the subject. The CES device will not be turned on at this point. This is similar to clinic practice, however in clinical practice any PCS staff trained in the use of the CES device may prepare and administer the CES device to the patient.
Next the AI will prepare the MindSet EEG device, ensure that it is functioning properly, and obtain signal acquisition. The AI will then explain the brainwave headset (MindSet) to the subject and properly place the headset on their head. Next a series of computer led activities to reduce extraneous artifacts (such as eye blink and muscle movement) will be completed by the subject. Following this, a baseline test measuring brainwave frequencies will be completed by the subject. This will last 30 seconds. Once this is completed, the CES device can be turned on and activated for 20 minutes. The CES micro amperage will be set by the subject based on therapeutic dose and locked in place on the CES device. Immediately following the completion of the 20 minute CES session, an EEG brainwave measure will be completed. Additional brainwave measure will be taken 5 minutes and 10 minutes post the CES session. Each of these brainwave measures will last 30 seconds.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychiatric Disorder
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Brainwave
Arm Type
Experimental
Arm Description
Brainwave analysis after cranial electric stimulation
Intervention Type
Device
Intervention Name(s)
Cranial Electric Stimulation
Intervention Description
Micro amperage TCDS
Primary Outcome Measure Information:
Title
Quantitative EEG Analysis
Description
The investigators used a commercially available EEG headset (Neurosky MindSet) in combination with EEG software (SmartMind) to obtain and analyze the Quantitative EEG from the subjects. The combination of the EEG headset with the software identified the five brainwave frequencies that are clinically relevant in studying EEG activity: Alpha, Beta, Delta, Gamma, and Theta. The combination of the headset and software reported changes in brainwave amplitude in microvolts for each brainwave frequency. Alpha waves increase with relaxation and drowsiness; and Beta waves, increase with wakefulness and concentration. Delta and Theta waves increase during meditative states and Gamma may suggest brain synchronicity.
Time Frame
Quantitative EEG collected at baseline (immediately before stimulation), immediately after 20 minutes of stimulation and then 5 and 10 minutes post stimualtion. Each of these four measures will record 30 seconds of brainwave activity
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Inclusion Criteria All prospective subjects will be active duty service members who are enrolled in PCS
Exclusion Criteria:
• Subjects will be excluded who have a seizure disorder, a cardiac pacemaker, or active untreated vertigo.
Subjects will be excluded if they have used CES the day of the study. However, they may participate in the study the following day.
Female subjects who are or who suspect they may be pregnant.
Subjects will also be excluded who are clinically judged by the investigators to be actively suicidal or have another psychiatric condition that would require inpatient hospitalization
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29360291
Citation
Lande RG, Gragnani CT. Prospective Study of Brain Wave Changes Associated With Cranial Electrotherapy Stimulation. Prim Care Companion CNS Disord. 2018 Jan 18;20(1):17m02214. doi: 10.4088/PCC.17m02214.
Results Reference
derived
Learn more about this trial
Brainwave Changes and Cranial Electrotherapy Stimulation
We'll reach out to this number within 24 hrs